ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Renal function"

  • 2016 American Transplant Congress

    Evaluation of the Long-Term Outcomes with Everolimus After Calcineurin Inhibitor Withdrawal: 36M Results of the H2304 and PROTECT Extension Studies.

    L. Fischer,1,2 J. Fung,1 H. Metselaar,1 G. Kaiser,1,2 P. Schemmer,2 P. Neuhaus,2 G. Dong,3 P. Lopez,4 P. Bernhardt,4 H. Schlitt.2

    1H2304 study group, Hamburg, Germany; 2PROTECT study group, Hamburg, Germany; 3Novartis Pharmaceuticals Corporation, East Hanover, NJ; 4Novartis Pharma AG, Basel, Switzerland.

    Background: The H2304 and PROTECT studies demonstrated reduced nephrotoxicity with everolimus (EVR)-based calcineurin inhibitor (CNI; cyclosporine: CsA, tacrolimus: TAC)-free regimens at Month (M) 12. Here,…
  • 2016 American Transplant Congress

    TRANSFORM: A Modern Approach to Evaluate Long-Term Outcomes of Everolimus with Reduced-Calcineurin Inhibitors in De Novo Kidney Transplant Recipients[mdash]Baseline Characteristics.

    M. Henry.

    On behalf of the TRANSFORM Investigators, Division of Transplantation Surgery, Wexner Medical Center, The Ohio State University, Columbus, OH.

    Purpose: Acute rejection and poor graft function are two major risk factors for allograft failure in kidney transplant (KTx) recipients (KTxR). Although, graft survival and…
  • 2016 American Transplant Congress

    Impact on Renal Function of Stepwise Withdrawal of Tacrolimus Combined with Everolimus and EC-MPS vs Standard Treatment Combining Tacrolimus and EC-MPS in De Novo Liver Transplant Recipients: Results of the SIMCER Study.

    F. Saliba,1 C. Duvoux,2 S. Dharancy,3 J. Dumortier,4 Y. Calmus,5 F. Di Giambattista,6 F. Conti.5

    1Hôpital Paul Brousse, Villejuif, France; 2Hôpital Henri Mondor, Créteil, France; 3Hôpital Claude Huriez, Lille, France; 4Hôpital Edouard Herriot, Lyon, France; 5Hôpital La Pitié-Salpêtrière, Paris, France; 6Novartis Pharma SAS, Rueil-Malmaison, France.

    Introduction: Long-term post-liver transplant (LTx) complications, particularly impaired renal function (RF) and its consequences, remain a concern. Presented here are the results of the SIMCER…
  • 2016 American Transplant Congress

    The Importance of KDPI in Simultaneous Liver and Kidney Transplant.

    E. Chan,1 M. Hertl,1 J. Perkins.2

    1General Surgery, Rush University Medical Center, Chicago, IL; 2Surgery, University of Washington, Seattle, WA.

    Background: The use of the Donor Risk Index (DRI) in liver transplantation and the Kidney Donor Profile Index (KDPI) in kidney transplantation has been well…
  • 2016 American Transplant Congress

    Short-Term Post-Donation Renal Function in Living Kidney Donors.

    L. Fahmy, A. Massie, A. Muzaale, S. Sandal, E. Chow, D. Segev.

    JHU, Baltimore.

    Previous single-center studies of post-donation estimated glomerular filtration rate (eGFR) in living kidney donors were limited by small sample size and lack of generalizability. The…
  • 2016 American Transplant Congress

    Comparing Renal Function After Liver Transplantation: Modified Piggyback versus Conventional Techniques without Venovenous Bypass.

    J. Lee, J. Lee, S. Song, J. Lee, S.-K. Kwon, D. Han, M. Ju, G. Choi, J. Choi, M. Kim, S. Kim, D. Joo.

    Surgery, Yonsei University College of Medicine, Seoul, Korea.

    BackgroundThere are several options available for caval reconstruction in liver transplantation. Prior reports demonstrated that caval reconstruction technique could affect the renal function. However, there…
  • 2015 American Transplant Congress

    DNA Methylation Classifier Associates With Long-Term Graft Function Post-Kidney Transplantation

    J. Suh,1 D. Maluf, K. Archer,2 T. Lee,1 L. Gallon,3 V. Mas.1

    1UVA, Charlottesville, VA; 2VCU, Richmond, VA; 3Noerthwestern University, Chicago, IL.

    "Background. Late graft failure is a major problem after kidney transplantation (KT) mainly due to chronic renal allograft dysfunction (CRAD). Data about common pathways of…
  • 2015 American Transplant Congress

    Non-Invasive Panel of MicroRNAs Predict Long-Term Outcomes Post-Kidney Transplantation

    J. Suh,1 D. Maluf,1 H. Cathro,2 R. Gehrau,1 I. McConnell,1 K. Brayman,1 C. Dumur,2 V. Mas.1

    1Surgery and Pathology, UVA, Charlottesville, VA; 2VCU, Richmond, VA.

    Background. Currently available methods for evaluating kidney graft function post-transplantation (KT) are either ineffective or inaccurate (e.g., serum creatinine) or highly invasive (e.g., biopsies). We…
  • 2015 American Transplant Congress

    High Intra-Patient Variability in Tacrolimus Trough Blood Levels Increases the Risk of Death-Censored Graft Loss After Kidney Transplantation

    E. Rodrigo,1 D. San Segundo,2 J. Ruiz,1 M. López-Hoyos,2 A. Benito,1 M. de Cos,3 Z. Albines,1 M. Serrano,1 M. Arias.1

    1Nephrology, University Hospital Marqués de Valdecilla, Santander, Cantabria, Spain; 2Immunology, University Hospital Marqués de Valdecilla, Santander, Cantabria, Spain; 3Pharmacology, University Hospital Marqués de Valdecilla, Santander, Cantabria, Spain.

    Kidney graft loss rates beyond the first year showed only small improvements over past decades. Advances in maintenance immunosuppressive therapy contributed to the improvements seen…
  • 2015 American Transplant Congress

    Replacement of Lamivudine By Telbivudine to Improve Renal Function for Post-Transplant Hepatitis B Patients – A Randomized Clinical Trial

    W.-C. Lee, H.-S. Chou, R.-S. Soong, T.-J. Wu, C.-H. Cheng, Y.-C. Wang, T.-H. Wu, C.-F. Lee, K.-M. Chan.

    Liver and Transplantation Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan.

    Background: Lamivudine is one of the anti-hepatitis B virus (HBV) agents to prevent HBV recurrence after transplantation because lamivudine is safe for long-term use. However,…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences